Robot maker · registered
Capstan Medical
Robotic catheter-based delivery platform combined with next-generation heart valve implants for minimally invasive treatment of structural heart disease; targets mitral and tricuspid valve repair/replacement; system integrates novel implant delivery with a robotic platform to address limitations of both open surgery and existing catheter-based options; 75+ employees across engineering, operations, clinical, and regulatory; first-in-human mitral procedure and pivotal trial planned.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
Structural Heart Robotic Delivery System
- Catheter-based robotic delivery platform combining novel transcatheter heart valve implants with robotic precision; designed for minimally invasive mitral and tricuspid valve replacement/repair without open surgery
Vendor-stated design approach and primary indication for the robotic structural heart platform
Claim source
Deployment log
Announced and cited only
Funding history
Publicly announced rounds
Series C
Eclipse, Gideon Strategic Partners, Intuitive Ventures, Yu Galaxy
Round sourceSeries B
Eclipse, Intuitive Ventures, Puma Venture Capital
Round sourceUndisclosed
Investors undisclosed
Round sourceHiring signal
Public job board · 2026-07-13
Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.
Company timeline
Milestones and announcements
Source ledger
4 unique public sources